RegulatoryAlerts Logo
RegulatoryAlerts
InsightsBlogPricingSign InStart Free Trial
All HSA (Singapore) updates
HSA (Singapore)
REGULATORY UPDATE
Regulatory Updates|28 Jan 2026
Published: 5/24/2026Detected: 4/11/2026

Summary preview

Regulatory Updates: Guidance on Product Defect Reporting and Recall Procedures for Therapeutic Products and Cells, Tissue and Gene Therapy Products (effective 28 Jan 2026) As part of HSA’s ongoing initiative to improve…

Get the full analysis, free

Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.

Create free account

Official Source Document
Source Verified

Access the original document directly from HSA.

View Official Document

More from HSA (Singapore)

  • Safety Alerts|02 Jan 20255/25/2026
  • Safety Alerts|27 Feb 20255/25/2026
  • Safety Alerts|06 Mar 20255/25/2026
  • Safety Alerts|13 Mar 20255/25/2026
  • Safety Alerts|08 Apr 20255/25/2026

Get HSA (Singapore) alerts in your inbox as they are published.

Free plan, 2-minute setup, no credit card required.

RegulatoryAlerts Logo
RegulatoryAlerts

Automated regulatory intelligence monitoring for pharmaceutical and biotech professionals. Track FDA, EMA, and Health Canada updates seamlessly.

Product

  • Insights
  • Updates by Therapeutic Area
  • FDA Updates
  • EMA Updates
  • Pricing
  • Features
  • Request Demo

Resources

  • Integration Guides
  • Regulatory Glossary
  • EMA Timeline
  • Best Practices
  • Therapeutic Areas

Company

  • About Us
  • Blog
  • Contact
  • Security
  • Privacy Policy
  • Terms of Service

    • © 2026 RegulatoryAlerts. All rights reserved.

    Not affiliated with the FDA, EMA, or Health Canada.